Andere talen Biocartis Group NV

Aandelen

BCART

BE0974281132

Beurs gesloten - Euronext Bruxelles Andere beurzen 17:35:06 22-09-2023			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,29 ^EUR	+1,05%		-.--%	-.--%

15/05	FSMA waarschuwt voor laattijdig publiceren jaarverslag	AM
09/05	Biocartis stelt publicatie jaarverslag uit	AM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Press release Biocartis Group NV: Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting	09/05
Biocartis, Merck KGaA Expand Cancer Biomarker Testing Collaboration into MENA Region	06/05
Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of major shareholdings)	10/01
Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of large shareholdings)	10/01
Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of large shareholdings)	10/01
Press release Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion	22/11
Press release Biocartis NV: Biocartis Hosts Corporate Workshop and Announces Seven Idylla™ Abstracts to be Presented at AMP 2023 Annual Meeting	13/11
Press release Biocartis Group NV: Announcement regarding Enforcement by Secured Creditors	31-10-23
Press release Biocartis Group NV: Four Abstracts Showing Excellent Data for Idylla™ Presented at European Society of Molecular Oncology Congress (ESMO)	20-10-23
Biocartis Group NV Presents Four Abstracts Showing Excellent Data for Idylla at European Society of Molecular Oncology Congress	20-10-23
Press release Biocartis Group NV: Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio	16-10-23
Press release Biocartis Group NV: Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio	16-10-23
Biocartis, APIS Assay Technologies to Commercialize Estrogen Receptor-positive Mutations Kit	12-10-23
Press release Biocartis Group NV: Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit	12-10-23
Biocartis Group NV Announces Expansion of Its Collaboration with APIS Assay Technologies Ltd to Commercialize the APIS ESR1 Mutations Kit	12-10-23
Press Release Biocartis Group NV: Disclosure of transparency notification	03-10-23
Tragedies on Brussels stock market: these two former star stocks are now worth virtually 0 euros	26-09-23
Biocartis shareholders see their investment go up in smoke with planned stock market exit	26-09-23
Biocartis Winding Down Begins with Creditors' Takeover of Operating Units	26-09-23
Press Release Biocartis Group NV: Agreement regarding recapitalization of operating subsidiaries by secured by secured creditors and wind down of listed holding company	26-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Biocartis Group NV

Aandelen

BCART

BE0974281132

Andere talen

Filters